{"id":"https://openalex.org/W7225097706","doi":"https://doi.org/10.1177/1540658x261495803","title":"Formulation, In Vitro and In Vivo Evaluation of Lutein\u2013Myo-Inositol Microspheres in a Letrozole-Induced Rat Model of PCOS","display_name":"Formulation, In Vitro and In Vivo Evaluation of Lutein\u2013Myo-Inositol Microspheres in a Letrozole-Induced Rat Model of PCOS","publication_year":2026,"publication_date":"2026-11-02","ids":{"openalex":"https://openalex.org/W7225097706","doi":"https://doi.org/10.1177/1540658x261495803","pmid":"https://pubmed.ncbi.nlm.nih.gov/42970458"},"language":"en","primary_location":{"id":"doi:10.1177/1540658x261495803","doi":"https://doi.org/10.1177/1540658x261495803","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1540658x261495803","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102720118","display_name":"Snigdha Bhardwaj","orcid":"https://orcid.org/0000-0002-6933-088X","observed_orcids":["https://orcid.org/0000-0002-6933-088X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Snigdha Bhardwaj","raw_affiliation_strings":["KIET School of Pharmacy, Krishna Institute of Engineering &amp; Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India"],"raw_orcid":"https://orcid.org/0000-0002-6933-088X","affiliations":[{"raw_affiliation_string":"KIET School of Pharmacy, Krishna Institute of Engineering &amp; Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132783866","display_name":"Nikita Sharma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikita Sharma","raw_affiliation_strings":["KIET School of Pharmacy, Krishna Institute of Engineering &amp; Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KIET School of Pharmacy, Krishna Institute of Engineering &amp; Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109645038","display_name":"Khushi Sharma","orcid":"https://orcid.org/0009-0008-7802-0745","observed_orcids":["https://orcid.org/0009-0008-7802-0745"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khushi Sharma","raw_affiliation_strings":["KIET School of Pharmacy, Krishna Institute of Engineering &amp; Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KIET School of Pharmacy, Krishna Institute of Engineering &amp; Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103916620","display_name":"Kandasamy Nagarajan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405262983","display_name":"IIMT University","ror":"https://ror.org/00zncbw15","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405262983"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Kandasamy Nagarajan","raw_affiliation_strings":["College of Medical Sciences (Pharmacy), IIMT University, Ganganagar, Meerut, Uttar Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Medical Sciences (Pharmacy), IIMT University, Ganganagar, Meerut, Uttar Pradesh, India","institution_ids":["https://openalex.org/I4405262983"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102720118"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82570175,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1540658X261495803","last_page":"1540658X261495803"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.8202999830245972,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.8202999830245972,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.16380000114440918,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polycystic-ovary-syndrome","display_name":"polycystic ovary syndrome","score":0.9940000176429749},{"id":"https://openalex.org/keywords/lutein","display_name":"lutein","score":0.9950000047683716},{"id":"https://openalex.org/keywords/myo-inositol","display_name":"myo-inositol","score":1.0},{"id":"https://openalex.org/keywords/microspheres","display_name":"microspheres","score":0.7639999985694885},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8730000257492065},{"id":"https://openalex.org/keywords/letrozole-induced-pcos","display_name":"letrozole-induced PCOS","score":0.8360000252723694},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.7910000085830688},{"id":"https://openalex.org/keywords/antioxidant-activity","display_name":"antioxidant activity","score":0.5299999713897705},{"id":"https://openalex.org/keywords/ovarian-histopathology","display_name":"ovarian histopathology","score":0.6779999732971191},{"id":"https://openalex.org/keywords/follicular-development","display_name":"folliculogenesis","score":0.6970000267028809},{"id":"https://openalex.org/keywords/emulsification-method","display_name":"emulsification method","score":0.6460000276565552},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.7879999876022339},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.5830000042915344},{"id":"https://openalex.org/keywords/polyherbal-formulation","display_name":"polyherbal formulation","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7710999846458435},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5364000201225281},{"id":"https://openalex.org/C2778411929","wikidata":"https://www.wikidata.org/wiki/Q422067","display_name":"Lutein","level":3,"score":0.492000013589859},{"id":"https://openalex.org/C3018442814","wikidata":"https://www.wikidata.org/wiki/Q500816","display_name":"Polycystic ovary","level":4,"score":0.4724999964237213},{"id":"https://openalex.org/C2778401633","wikidata":"https://www.wikidata.org/wiki/Q418661","display_name":"Malondialdehyde","level":3,"score":0.4715999960899353},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.46810001134872437},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4553999900817871},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.45190000534057617},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4496000111103058},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4494999945163727},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4422000050544739},{"id":"https://openalex.org/C538909803","wikidata":"https://www.wikidata.org/wiki/Q116907","display_name":"Glutathione","level":3,"score":0.4408000111579895},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4246000051498413},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.41359999775886536},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.39899998903274536},{"id":"https://openalex.org/C10162356","wikidata":"https://www.wikidata.org/wiki/Q1135939","display_name":"Pathophysiology","level":2,"score":0.37400001287460327},{"id":"https://openalex.org/C2778760513","wikidata":"https://www.wikidata.org/wiki/Q24773045","display_name":"Glutathione peroxidase","level":4,"score":0.3513000011444092},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3434999883174896},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.325300008058548},{"id":"https://openalex.org/C189942447","wikidata":"https://www.wikidata.org/wiki/Q61186","display_name":"Microsphere","level":2,"score":0.32510000467300415},{"id":"https://openalex.org/C102652120","wikidata":"https://www.wikidata.org/wiki/Q2419430","display_name":"Therapeutic effect","level":2,"score":0.30630001425743103},{"id":"https://openalex.org/C2778324911","wikidata":"https://www.wikidata.org/wiki/Q9631","display_name":"Ovary","level":2,"score":0.28700000047683716},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.26510000228881836},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2563000023365021}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1177/1540658x261495803","doi":"https://doi.org/10.1177/1540658x261495803","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1540658x261495803","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},{"id":"pmid:42970458","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42970458","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Assay and drug development technologies","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W97305611","https://openalex.org/W1502642867","https://openalex.org/W1577097214","https://openalex.org/W1924593288","https://openalex.org/W1933438813","https://openalex.org/W1969062482","https://openalex.org/W1979982507","https://openalex.org/W1981895394","https://openalex.org/W1986879910","https://openalex.org/W1986902166","https://openalex.org/W1986962958","https://openalex.org/W2013162741","https://openalex.org/W2014608817","https://openalex.org/W2037342776","https://openalex.org/W2042212286","https://openalex.org/W2058294720","https://openalex.org/W2058308524","https://openalex.org/W2059774520","https://openalex.org/W2085223433","https://openalex.org/W2114539404","https://openalex.org/W2146569034","https://openalex.org/W2168738933","https://openalex.org/W2186218348","https://openalex.org/W2257058354","https://openalex.org/W2318801071","https://openalex.org/W2610687040","https://openalex.org/W2809960611","https://openalex.org/W2900701301","https://openalex.org/W2946423640","https://openalex.org/W2949825098","https://openalex.org/W2961778046","https://openalex.org/W3011966340","https://openalex.org/W3048753345","https://openalex.org/W3096809272","https://openalex.org/W3104254993","https://openalex.org/W3114360973","https://openalex.org/W3162257103","https://openalex.org/W3183452167","https://openalex.org/W4200334807","https://openalex.org/W4210987256","https://openalex.org/W4220973560","https://openalex.org/W4228999383","https://openalex.org/W4253521212","https://openalex.org/W4292809162","https://openalex.org/W4300089712"],"related_works":["https://openalex.org/W4366607373","https://openalex.org/W7222084465","https://openalex.org/W4403588659","https://openalex.org/W4410332372","https://openalex.org/W4414566734","https://openalex.org/W4415503100","https://openalex.org/W3158066018","https://openalex.org/W4410462211","https://openalex.org/W7224901145","https://openalex.org/W4416416206"],"abstract_inverted_index":{"Polycystic":[0],"ovary":[1],"syndrome":[2],"(PCOS)":[3],"is":[4,108],"a":[5,79,215,275,284],"prevalent":[6],"and":[7,31,38,51,63,74,86,116,130,138,152,175,197,221,265,279,297],"complex":[8],"hormone-metabolic":[9],"condition":[10],"that":[11,274],"impacts":[12],"females":[13],"of":[14,28,98,103,132,179,223,240,257,277],"reproductive":[15],"age.":[16],"Current":[17],"pharmacological":[18],"treatments":[19],"often":[20],"address":[21],"limited":[22,39,112],"symptoms,":[23],"may":[24],"involve":[25],"long-term":[26],"use":[27],"synthetic":[29],"drugs,":[30],"are":[32,301],"frequently":[33],"associated":[34],"with":[35,203],"adverse":[36],"effects":[37],"patient":[40],"adherence.":[41],"In":[42,185],"recent":[43],"years,":[44],"natural":[45],"therapeutic":[46],"agents":[47],"such":[48],"as":[49],"Lutein":[50,137,278],"Myo-inositol":[52,139],"have":[53],"acquired":[54],"increasing":[55],"interest":[56],"due":[57],"to":[58,148,303],"their":[59,111],"promising":[60],"biological":[61],"properties":[62],"minimal":[64],"side":[65],"effects.":[66],"Strong":[67],"antioxidant":[68],"lutein":[69],"aids":[70],"in":[71,106,155,218,227,232,243,262],"lowering":[72],"inflammation":[73],"oxidative":[75,291],"stress,":[76,292],"while":[77],"Myo-inositol,":[78,280],"naturally":[80],"occurring":[81],"sugar":[82],"alcohol,":[83],"has":[84],"insulin-sensitizing":[85],"ovulation-inducing":[87],"effects,":[88],"making":[89],"them":[90],"ideal":[91],"candidates":[92],"for":[93,154],"addressing":[94],"the":[95,101,123,128,141,159,186,204,228,252,272],"multifaceted":[96],"pathophysiology":[97],"PCOS.":[99],"Nevertheless,":[100],"application":[102],"these":[104,121],"compounds":[105],"therapy":[107],"restricted":[109],"by":[110],"solubility,":[113],"reduced":[114,193],"bioavailability,":[115],"brief":[117],"half-life.":[118],"To":[119],"overcome":[120],"challenges,":[122],"present":[124],"research":[125],"focused":[126],"on":[127],"development":[129],"assessment":[131],"sustained-release":[133,285],"poly-herbal":[134],"microspheres":[135],"incorporating":[136],"using":[140],"emulsification":[142],"method.":[143],"Nine":[144],"different":[145],"formulations":[146,161],"(F1":[147],"F9)":[149],"were":[150],"prepared":[151],"characterized":[153],"vitro":[156],"parameters.":[157],"Among":[158],"nine":[160],"developed,":[162],"one":[163],"optimized":[164],"formulation":[165],"demonstrated":[166,255],"high":[167],"encapsulation":[168],"efficiency":[169],"(>90%),":[170],"satisfactory":[171],"production":[172],"yield":[173],"(>85%),":[174],"sustained":[176],"drug":[177],"release":[178],"approximately":[180],"90%":[181],"over":[182],"8":[183],"h.":[184],"letrozole-induced":[187],"PCOS":[188,304],"rat":[189],"model,":[190],"treatment":[191],"significantly":[192],"malondialdehyde":[194],"(MDA)":[195],"levels":[196,201],"increased":[198],"glutathione":[199],"(GSH)":[200],"compared":[202],"disease":[205],"control":[206],"group":[207],"(":[208],"p":[209],"<":[210],"0.001).":[211],"Histopathological":[212],"evaluation":[213],"showed":[214],"marked":[216],"reduction":[217,261],"cystic":[219,263],"follicles":[220],"restoration":[222,256],"normal":[224,258],"ovarian":[225,241,259,298],"morphology":[226],"treated":[229,247],"group.":[230],"Furthermore,":[231],"vivo":[233],"efficacy":[234],"was":[235],"confirmed":[236],"through":[237,283],"histopathological":[238],"examination":[239],"tissues":[242],"animal":[244],"models,":[245],"where":[246],"groups,":[248],"especially":[249],"T3,":[250],"receiving":[251],"highest":[253],"concentration":[254],"architecture,":[260],"follicles,":[264],"improved":[266],"follicular":[267],"development.":[268],"These":[269],"outcomes":[270],"support":[271],"hypothesis":[273],"combination":[276],"when":[281],"delivered":[282],"microsphere":[286],"system,":[287],"can":[288],"effectively":[289],"target":[290],"insulin":[293],"resistance,":[294],"hormonal":[295],"imbalance,":[296],"dysfunction,":[299],"which":[300],"central":[302],"pathogenesis.":[305]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-11-03T00:00:00"}